Eberhard Ritz
Impact in
- Nephrology top 0.01%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Parathyroid Disorders and Treatments
- Renal Diseases and Glomerulopathies
- Cardiology and Cardiovascular Medicine top 0.05%
- Blood Pressure and Hypertension Studies
- Renin-Angiotensin System Studies
Papers in
- Nephrology 387
- Parathyroid Disorders and Treatments 137
- Dialysis and Renal Disease Management 126
- Chronic Kidney Disease and Diabetes 118
- Renal Diseases and Glomerulopathies 55
-
- Blood Pressure and Hypertension Studies 95
- Renin-Angiotensin System Studies 47
- Co-authors
- Stephan R. Orth (33 shared papers)Kerstin Amann (71 shared papers)Danilo Fliser (38 shared papers)Johannes F.E. Mann (31 shared papers)Winfried März (38 shared papers)Christoph Wanner (25 shared papers)Tomás Berl (4 shared papers)Lawrence G. Hunsicker (3 shared papers)
- Journals
- Nephrology Dialysis Transplantation (124 papers)Kidney International (71 papers)Journal of the American Society of Nephrology (58 papers)Journal of Molecular Medicine (34 papers)The Nephron journals/Nephron journals (25 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Eberhard Ritz
880 papers receiving 42.4k citations
Eberhard Ritz's Hit Papers
Peers
Comparison fields: 5 of 182
- Nephrology 16.5k
- Cardiology and Cardiovascular Medicine 10.1k
- Endocrinology, Diabetes and Metabolism 7.2k
- Transplantation 667
- Pathology and Forensic Medicine 4.0k
Countries citing papers authored by Eberhard Ritz
This map shows the geographic impact of Eberhard Ritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Ritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Ritz more than expected).
Fields of papers citing papers by Eberhard Ritz
This network shows the impact of papers produced by Eberhard Ritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Ritz. The network helps show where Eberhard Ritz may publish in the future.
Co-authors
The 25 scholars most cited alongside Eberhard Ritz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 934 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes Hit paper breakdown → | 2001 | 4328 |
| 2 | Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis Hit paper breakdown → | 2005 | 1813 |
| 3 | Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency Hit paper breakdown → | 1996 | 1336 |
| 4 | The Heidelberg classification of renal cell tumours Hit paper breakdown → | 1997 | 1039 |
| 5 | Nephron Number in Patients with Primary Hypertension Hit paper breakdown → | 2003 | 764 |
| 6 | Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) Hit paper breakdown → | 2011 | 664 |
| 7 | Association of a human G-protein β3 subunit variant with hypertension Hit paper breakdown → | 1998 | 615 |
| 8 | Nephropathy in Patients with Type 2 Diabetes Mellitus Hit paper breakdown → | 1999 | 594 |
| 9 | Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease Hit paper breakdown → | 2007 | 572 |
| 10 | Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial Hit paper breakdown → | 2010 | 524 |
| 11 | Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes Hit paper breakdown → | 2011 | 524 |
| 12 | Essential hypertension Hit paper breakdown → | 2007 | 518 |
| 13 | 1998 | 342 | |
| 14 | 2002 | 326 | |
| 15 | 2009 | 324 | |
| 16 | 2002 | 306 | |
| 17 | 2001 | 305 | |
| 18 | 2009 | 299 | |
| 19 | 1989 | 277 | |
| 20 | 2005 | 274 |
About Eberhard Ritz
Eberhard Ritz is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 934 papers that have together received 44.4k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (137 papers), Dialysis and Renal Disease Management (126 papers), Chronic Kidney Disease and Diabetes (118 papers), Blood Pressure and Hypertension Studies (95 papers), Renal Diseases and Glomerulopathies (55 papers), Electrolyte and hormonal disorders (55 papers), Vitamin D Research Studies (53 papers) and Renin-Angiotensin System Studies (47 papers). The work is most often cited by research in Nephrology (16.5k citations), Cardiology and Cardiovascular Medicine (10.1k citations), Endocrinology, Diabetes and Metabolism (7.2k citations), Transplantation (667 citations) and Pathology and Forensic Medicine (4.0k citations). Eberhard Ritz has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Stephan R. Orth, Kerstin Amann, Danilo Fliser, Johannes F.E. Mann, Winfried März, Christoph Wanner, Tomás Berl, Lawrence G. Hunsicker, Edmund J. Lewis and Julia B. Lewis. Their work appears in journals such as Nephrology Dialysis Transplantation, Kidney International, Journal of the American Society of Nephrology, Journal of Molecular Medicine and The Nephron journals/Nephron journals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.